| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 38.967 | 34.262 | 40.016 | 42.064 | 47.711 | 63.328 | 146.798 | 159.520 | 181.767 | 194.054 |
| Total Income - EUR | 38.967 | 34.274 | 40.032 | 42.085 | 47.712 | 63.328 | 146.799 | 162.252 | 184.328 | 199.613 |
| Total Expenses - EUR | 33.040 | 29.957 | 37.433 | 41.572 | 44.190 | 48.679 | 95.180 | 106.707 | 95.636 | 123.076 |
| Gross Profit/Loss - EUR | 5.928 | 4.317 | 2.599 | 513 | 3.522 | 14.649 | 51.619 | 55.545 | 88.692 | 76.537 |
| Net Profit/Loss - EUR | 4.759 | 3.974 | 2.199 | 92 | 3.045 | 14.016 | 50.254 | 53.923 | 86.849 | 70.671 |
| Employees | 2 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Neuro-Ex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.041 | 7.493 | 18.883 | 16.007 | 15.492 | 12.813 | 30.325 | 26.322 | 22.157 | 268.033 |
| Current Assets | 33.963 | 39.806 | 8.965 | 6.541 | 29.363 | 38.189 | 55.062 | 70.187 | 90.981 | 63.749 |
| Inventories | 1.595 | 1.543 | 1.762 | 2.307 | 5.593 | 2.122 | 2.075 | 2.082 | 2.075 | 10.991 |
| Receivables | 1.575 | 2.651 | 3.692 | 2.183 | 22.355 | 31.340 | 4.937 | 2.006 | 12.570 | 13.994 |
| Cash | 30.793 | 35.611 | 3.510 | 2.050 | 1.415 | 4.727 | 48.050 | 66.099 | 76.336 | 38.765 |
| Shareholders Funds | 46.229 | 49.731 | 21.133 | 20.837 | 23.478 | 37.049 | 73.746 | 85.207 | 97.085 | 78.071 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.888 | 1.561 | 9.592 | 5.041 | 23.632 | 13.953 | 11.642 | 11.301 | 16.053 | 60.663 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 195.139 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro-Ex Srl